Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beam Therapeutics, Inc.

19.87
+0.74003.87%
Post-market: 20.000.1300+0.65%17:35 EDT
Volume:2.13M
Turnover:43.17M
Market Cap:2.00B
PE:-4.34
High:20.81
Open:20.00
Low:19.85
Close:19.13
Loading ...
Sep 21, 2023

Correspondence

Form CORRESP - Correspondence
Aug 10, 2023

Correspondence

Form CORRESP - Correspondence
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Jul 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 08, 2023

Major Issues Report

Form 8-K - Current report
May 10, 2023

Major Issues Report

8-K - Current report
May 10, 2023

Major Issues Report

8-K - Current report
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 17, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 07, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]